Cholestyramine therapy in patients with a paucity of intrahepatic bile ducts.
D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D001647:Bile Acids and Salts / Q000097:blood; D001653:Bile Ducts, Intrahepatic; D001663:Bilirubin / Q000097:blood; D001827:Body Height; D001835:Body Weight; D002648:Child; D002675:Child, Preschool; D002758:Cholangiography; D002779:Cholestasis / Q000209:etiology; D002792:Cholestyramine Resin / Q000627:therapeutic use*; D005243:Feces; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000209:etiology; D008107:Liver Diseases / Q000188:drug therapy* / Q000652:urine; D008111:Liver Function Tests; D008297:Male; D011537:Pruritus / Q000188:drug therapy*
D001647:Bile Acids and Salts; D002792:Cholestyramine Resin; D000469:Alkaline Phosphatase; D001663:Bilirubin